Skip to main content
Psyence Group Inc. logo

Psyence Group Inc. — Investor Relations & Filings

Ticker · PSYG ISIN · CA74449Q2053 LEI · 549300RPEOIVSD0MJC07 CSE Manufacturing
Open in API
Filings indexed 195 across all filing types
Latest filing 2025-07-08 Capital/Financing Update
Country CA Canada
Listing CSE PSYG

About Psyence Group Inc.

https://psyence.com/

Psyence Group Inc. is a science-led life science biotechnology company focused on the research, cultivation, and production of natural psychedelics and nature-based compounds. The company develops innovative, safe, and effective solutions for mental health. Its core clinical division, Psyence Therapeutics (now part of Psyence Biomedical Ltd.), pioneers the use of natural psilocybin formulations and treatment protocols, primarily targeting anxiety and depression within the context of palliative care. Supporting this effort, the company operates one of the world's first federally licensed, ISO22000 certified psilocybin cultivation and production facilities. Furthermore, Psyence Function markets a range of non-psychoactive functional mushroom wellness products utilizing adaptogens.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Capital/Financing Update Classification · 88% confidence The document is a Form 51-102F3 Material Change Report and accompanying news release announcing the closing of the second tranche of a non-brokered private placement and the issuance of new common shares for gross proceeds. This is a fundraising event and capital structure update via share issuance. According to the category definitions, this fits “Capital/Financing Update” (CAP) covering company fundraising and financing activities.
2025-07-08 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 72% confidence The document is a Canadian securities regulator form (Form 45-106F1) for reporting an exempt distribution of securities. It is a formal regulatory filing on SEDAR, not an earnings release, annual report, management discussion, or proxy. It does not match specific categories like AGM materials, MD&A, share repos or M&A, so it falls into the fallback “Regulatory Filings” category.
2025-07-08 English
News release - English.pdf
Capital/Financing Update Classification · 88% confidence The document is a press release announcing the closing of the second tranche of a non-brokered private placement, detailing share issuance amounts, subscription price, gross proceeds and intended use of funds. This is a fundraising/financing activity update rather than an earnings release, regulatory filing, or board/management change. It fits the Capital/Financing Update category.
2025-07-07 English
Material change report - English.pdf
Capital/Financing Update Classification · 91% confidence The document is a Form 51-102F3 Material Change Report and accompanying news release announcing the details of a non-brokered private placement of common shares, including share issuance, tranche closings, and gross proceeds. This constitutes an update on the company’s fundraising and changes to its capital structure. Therefore it falls under Capital/Financing Update (CAP).
2025-06-27 English
Report of exempt distribution (45-106F1).pdf
Capital/Financing Update Classification · 85% confidence The document is a completed Form 45-106F1 “Report of Exempt Distribution,” a Canadian regulatory disclosure detailing a private placement of 4.76 million new common shares at CAD 0.10, including purchaser breakdown, dates, amounts, and transaction schedules. This is not an annual or quarterly report, earnings release, or board change notice, but a financing activity reporting form. It best fits the Capital/Financing Update category, which covers updates on company fundraising or capital structure changes.
2025-06-27 English
News release - English.pdf
Capital/Financing Update Classification · 92% confidence The document is a press release announcing an update on a non-brokered private placement of common shares, detailing tranches, amounts raised, issuance price, use of proceeds, and hold periods. This is an update on company fundraising and capital structure change via share issuance, fitting the “Capital/Financing Update” definition. It is not a full financial report, governance item, dividend notice, or regulatory statement. Therefore it is classified as a Capital/Financing Update (CAP).
2025-06-25 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.